Navigation Links
Jennerex Appoints James M. Burke, M.D. Vice President, Clinical Research
Date:2/22/2011

SAN FRANCISCO, Feb. 22, 2011 /PRNewswire/ -- Jennerex, Inc. (San Francisco), a clinical-stage cancer biotherapeutics company, today announced the appointment of James M. Burke, M.D. to the newly-created position of vice president, clinical research. Dr. Burke will be responsible for all global clinical research activities related to Jennerex pipeline compounds.

"Dr. Burke has been working with Jennerex in an advisory capacity as a clinical advisor for over a year, and has provided significant contributions to the strategic direction and clinical development of JX-594 for the treatment of liver cancer, and we look forward to bringing his expertise in-house," said David H. Kirn, M.D., president and chief executive officer of Jennerex. "In addition, as we advance our earlier stage pipeline products, Dr. Burke's direct clinical research experience using immunotherapeutics to treat multiple solid tumors will be instrumental as we pursue continued development of JX-929, JX-1395 and our next generation products."

Dr. Burke brings approximately 20 years of experience in basic and applied clinical science of genetic and immunotherapy.  His clinical research using immunotherapeutics including oncolytic viruses for the treatment of various cancers have advanced the understanding of the medical applications for oncolytic virus therapy. Prior to Jennerex, Dr. Burke was the Director of Cancer Research at Billings Clinic, where he was also a clinical investigator for JX-594. He had previously served as associate director of clinical research at Cell Genesys, Inc., where he was responsible for the development of the oncolytic adenovirus platform of agents and other gene therapy vaccines for the treatment of cancer and other diseases.  In addition, after completing his Hematology and Oncology Fellowship at UC San Francisco (UCSF), he was an attending physician at UCSF in the department of hematology and oncology. He received his M.D. from Georgeto
'/>"/>

SOURCE Jennerex, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Jennerex and Transgene Enter Into an Exclusive Partnership for the Development and Commercialization of JX-594 for the Treatment of Cancers
2. Jennerex Completes Fully Subscribed Private Placement for Aggregate Gross Proceeds of $8.6 Million
3. Jennerex Reports Positive Phase 1 Results for JX-594 Administered Intravenously
4. Jennerex Adds Industry Veteran Paul Cleveland to Board of Directors
5. Jennerex Completes Over-Subscribed Series C Financing for Aggregate Gross Proceeds of Over $5.5 Million
6. Jennerex Closes $5 Million First Tranche of Series C Financing
7. Nature Reviews Publishes Article About Jennerexs Multi-Mechanistic Cancer Therapeutic
8. Jennerex Appoints Samantha Miller as Vice President of Corporate Development
9. Jennerex Completes $8.3 Million Series B Financing and Appoints Dr. Cal Stiller as Director
10. ALS Therapy Development Institute Appoints Anil Godhwani to Board of Directors
11. Amarin Corporation Appoints Industry Veteran Paul E. Huff as Chief Commercial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 22, 2014 The Board of Directors of BD ... declared a quarterly dividend of 54.5 cents per common share ... September 9, 2014. The indicated annual dividend rate is $2.18 ... is a leading medical technology company that partners with customers ... and evolving health needs. Our innovative solutions are focused on ...
(Date:7/22/2014)... Baughn, a senior lecturer in mechanical engineering at the ... of the Year by the North Texas section of ... has more than 130,000 members in 158 countries who ... to assist the engineering community, benefiting the world. , ... Society of Professional Engineers honors banquet. Baughn retired as ...
(Date:7/22/2014)... Automated cell culture systems are instruments that mechanically ... allow production of optimum cells at a large scale ... and industries and biopharmaceutical companies. Cell culture automation systems ... cell-based assays, and cellular expression systems as they save ... Global Cell Culture market will grow at ...
(Date:7/22/2014)... 2014 OHAUS Corporation, a leading ... balances and scales, proudly announces its Explorer line ... Equipment magazine’s 2014 “Readers' Choice” Award for ... the Explorer was voted the best laboratory balance ... Awards celebrates “excellence in product design and performance ...
Breaking Biology Technology:UT Dallas professor receives Engineer of the Year award 2Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 2Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 3Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 4OHAUS Explorer Voted “Best Balance” in Laboratory Equipment’s 2014 Readers’ Choice Awards 2
... MOUNTAINSIDE, N.J., Feb. 19 National Stem,Cell Holding, ... Burt,Martin Arnold Securities, Inc. ("BMA Securities") to provide ... and advising the,company with a current capital raise ... member full service brokerage firm. BMA,Securities offers a ...
... SAN FRANCISCO, Feb. 19 Inverseon, Inc.,( ... rapid,communication of groundbreaking research led by Professor ... Scientific Founder. In the March,article by Nguyen, ... Respiratory Cell and,Molecular Biology 2008; 38: 256-262, ...
... for Stem Cell Therapy in SMA,will begin in early ... Muscular Atrophy (FSMA); a stem cell scientist at University ... are pleased,to announce a partnership to advance a potential ... specific set of animal studies planned, which,will be conducted ...
Cached Biology Technology:National Stem Cell Holding, Inc. Has Engaged BMA Securities to Assist and Advise the Company With Its Current Capital Raise of $3,500,000 2Drug Reduces Airway Mucus in Preclinical Asthma Model 2Families of Spinal Muscular Atrophy; University of California, Irvine Stem Cell Scientist; and California Stem Cell Announce Collaboration for Safety Studies for Stem Cell Therapy in Spinal Muscular Atrophy 2Families of Spinal Muscular Atrophy; University of California, Irvine Stem Cell Scientist; and California Stem Cell Announce Collaboration for Safety Studies for Stem Cell Therapy in Spinal Muscular Atrophy 3
(Date:7/23/2014)... tapeworms, hookworms and a protist called Blastocystis can ... that argues we should rethink our views of organisms that ... paper co-author Julius Luke even ingested three developmental stages of ... After more than a year with the tapeworms, which might ... by now, he says he feels fine. , "I knew ...
(Date:7/23/2014)... Security forces worldwide rely on sophisticated equipment, trained ... other public areas against terrorist attacks. A revolutionary ... about to make their job much easier. , ... Patolsky of Tel Aviv University ,s School of ... developed by the Herzliya company Tracense, picks up ...
(Date:7/23/2014)... New York Stem Cell Foundation (NYSCF) and Beyond Batten ... resources to investigate and explore new treatments and ultimately ... illness affecting children. , NYSCF scientists will create induced ... young people affected by juvenile Batten disease as well ... by artificially "turning back the clock" on skin cells ...
Breaking Biology News(10 mins):Intestinal parasites are 'old friends,' researchers argue 2Intestinal parasites are 'old friends,' researchers argue 3Nano-sized chip "sniffs out" explosives far better than trained dogs 2NYSCF partners with Beyond Batten Disease Foundation to fight juvenile Batten disease 2NYSCF partners with Beyond Batten Disease Foundation to fight juvenile Batten disease 3
... Wash. An international team of scientists from Italy, France, ... sequence of the domestic apple genome in the current issue ... genome sequence for apple will allow scientists to more rapidly ... which genes and gene variants provide disease or drought resistance ...
... disorders are a chronic and often disabling condition. ... enormous burden to the patients and their relatives ... human suffering and societal expenditure. The ... in brain structure and changes in neurotransmission, with ...
... 2010) Although having a high body mass index ... researchers are only beginning to understand how BMI affects ... disease. Now, a study of a subset of women ... that as BMI increases, so do platelet reactivity and ...
Cached Biology News:Core knowledge of tree fruit expands with apple genome sequencing 2Core knowledge of tree fruit expands with apple genome sequencing 3Body mass index and thrombogenic factors in newly menopausal women 2Body mass index and thrombogenic factors in newly menopausal women 3